T3	Subject 10 24	three patients
T5	Effect 90 163	profound reduction in plasma HDL cholesterol and apolipoprotein AI levels
T6	Treatment 193 214	rosiglitazone therapy
T8	Population 10 15	three
T9	Drug 193 206	rosiglitazone
T10	Time_elapsed 164 174	soon after
T11	Treat-Disorder 42 75	preexisting diabetic dyslipidemia
T7	Potential_therapeutic_event 179 189	initiation
E1	Potential_therapeutic_event:T7